Four-Drug attack on tough stomach cancer
NCT ID NCT07289997
Summary
This study is testing a new combination of four drugs for people with an aggressive type of advanced stomach or gastroesophageal cancer that has continued to grow despite initial treatment with immunotherapy and chemotherapy. The goal is to see if this new drug mix can shrink tumors and control the disease. The study will enroll 39 adults whose cancer produces a specific protein (AFP) and has worsened after their first treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hebei Medical University Fourth Hospital
RECRUITINGShijiazhuang, Hebei, 050000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.